<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="29074">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02728232</url>
  </required_header>
  <id_info>
    <org_study_id>PP2302019</org_study_id>
    <nct_id>NCT02728232</nct_id>
  </id_info>
  <brief_title>Internal Iliac Artery Ligation and Placenta Percreta</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial is set to detect the impact of bilateral internal iliac artery ligation on the
      amount of intra-operative blood loss during the hysterectomy procedure done for the
      management of placenta percreta
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>amount of intra-operative hemorrhage</measure>
    <time_frame>2-3 hours</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Placenta Percreta</condition>
  <arm_group>
    <arm_group_label>Internal Iliac artery ligation group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>in this group the patients will undergo bilateral internal iliac artery ligation prior to the hysterectomy procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hysterectomy only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>in this group patients will undergo cesarean hysterectomy only</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>internal iliac artery ligation</intervention_name>
    <arm_group_label>Internal Iliac artery ligation group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cesarean Hysterectomy</intervention_name>
    <arm_group_label>Internal Iliac artery ligation group</arm_group_label>
    <arm_group_label>Hysterectomy only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  females with pre-operative diagnosis of placenta percreta

        Exclusion Criteria:

          -  refusal to get enrolled in the study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed M Hussein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ahmed M Hussein, MD</last_name>
    <phone>01223515652</phone>
    <phone_ext>002</phone_ext>
    <email>Ahmed_mhussein@live.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dina M Dakhly, MD</last_name>
    <phone>01003498919</phone>
    <phone_ext>002</phone_ext>
    <email>dinadakhly@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kasr el aini hospital</name>
      <address>
        <city>Cairo</city>
        <zip>12211</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed M Hussein, MD</last_name>
      <phone>01223515652</phone>
      <phone_ext>002</phone_ext>
      <email>ahmed_mhussein@live.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <lastchanged_date>April 4, 2016</lastchanged_date>
  <firstreceived_date>March 31, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Ahmed Mahmoud Hussein</investigator_full_name>
    <investigator_title>Lecturer of Obstetrics and Gynecology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Placenta Accreta</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
